Department of Ophthalmology and Vision Sciences, The University of Toronto, Toronto, Ontario, 1A1 Canada.
Sydney Eye Hospital, Sydney, NSW, 2000 Australia.
Med Mycol. 2022 Jul 8;60(7). doi: 10.1093/mmy/myac047.
Fungal keratitis is a devastating and difficult-to-treat ocular infection with high morbidity. Understanding geographic microbiological and clinical trends helps to guide rapid and effective treatment. We therefore report the characteristics and outcomes of fungal keratitis in Toronto,ON Canada, over a 20-year period. An electronic search of microbiology records at University Health Network, Toronto, ON, Canada identified all patients with positive corneal fungal culture over a 20-year period seen at our tertiary referral cornea practice. Review of corresponding patient charts identified demographic and microbiological details, clinical course, treatment regimen, and final outcomes associated with each episode of culture-positive fungal keratitis. A total of 46 patients with 51 discrete fungal keratitis episodes were included. Five patients experienced recurrent fungal keratitis. Candida species accounted for 60.8% of positive fungal cultures, followed by Filamentous species at 35.3%. Preferred initial anti-fungal treatment was topical amphotericin at 36.7% followed by topical voriconazole at 32.6%. Surgical intervention was required in 48.9% with therapeutic penetrating keratoplasty being the most common procedure (22.4%). Final visual acuity (VA) of <20/200 was attributed to 58% of patients in this study. Risk factors for poor outcomes included poor VA, topical steroid use at presentation, Candida involvement, history of ocular surface disease, organic ocular trauma, or prior corneal transplantation. Candida is the most frequent keratomycotic pathogen in Toronto. Risk factors for poor visual outcome include prior corneal transplantation, ocular surface disease/trauma, or pre-existing topical steroid use. Early suspicion, diagnosis and treatment are paramount for best clinical outcomes.
Fungal keratitis can cause severe vision loss without effective treatment. In Toronto, Candida had been the most common species over a 20-year period. Poor clinical outcome was associated with low presenting visual acuity, previous corneal transplant, topical steroid use, trauma, and Candida involvement.
真菌性角膜炎是一种破坏性的、难以治疗的眼部感染,发病率高。了解地理微生物学和临床趋势有助于指导快速有效的治疗。因此,我们报告了加拿大安大略省多伦多真菌性角膜炎的特征和结果,研究时间跨度为 20 年。在加拿大安大略省多伦多大学健康网络的微生物记录中进行了电子搜索,确定了在我们的三级转诊角膜诊所就诊的所有角膜真菌培养阳性患者。回顾相应的患者图表,确定了与每一次培养阳性真菌性角膜炎相关的人口统计学和微生物学细节、临床过程、治疗方案和最终结果。共纳入 46 例 51 例单纯性真菌性角膜炎患者。5 例患者发生复发性真菌性角膜炎。阳性真菌培养中,假丝酵母菌占 60.8%,丝状真菌占 35.3%。首选的初始抗真菌治疗是 36.7%的局部两性霉素 B,其次是 32.6%的局部伏立康唑。48.9%的患者需要手术干预,最常见的手术是治疗性穿透性角膜移植术(22.4%)。本研究中,58%的患者最终视力(VA)<20/200。预后不良的危险因素包括视力差、就诊时使用皮质类固醇、假丝酵母菌感染、眼表疾病史、眼部器质性创伤或既往角膜移植。在多伦多,假丝酵母菌是最常见的角膜真菌病原体。视力预后不良的危险因素包括既往角膜移植、眼表疾病/创伤或存在局部皮质类固醇。早期怀疑、诊断和治疗对于获得最佳临床结果至关重要。
真菌性角膜炎如果不及时治疗可能导致严重视力丧失。在多伦多,假丝酵母菌在 20 年期间一直是最常见的病原体。低就诊时视力、既往角膜移植、皮质类固醇使用、创伤和假丝酵母菌感染与不良临床结局相关。